BLISSGVS.NS

Bliss GVS Pharma Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$486.30

+1.53%Jun 19, 2026

AI Brief

Market cap

$51.45B

52w range

—

P / E

—

EPS · FY 2026

$12.00

Volume

—

Revenue · FY 2026

$9.27B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Bliss GVS Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$486.30

Change

+227.39%

Period high

$486.30

Period low

$127.90

Period start

$148.542025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$260.76

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

BLISSGVS.NS

486.30+227.39%

H 493.75L 118.00MA50 331.50MA200 213.60Avg vol 2.6M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for BLISSGVS.NS.

Peers

No peer list available for BLISSGVS.NS.

Total assets

$14.92B

Total debt

$217.5M

Cash & equiv

$351.42M

Operating CF

$1.39B

Free cash flow

$818.87M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$9.27B	$1.31B	$1.29B	$12.00	+13.93%